A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan
A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quanti...
        Saved in:
      
    
          | Published in | YAKUGAKU ZASSHI Vol. 137; no. 7; pp. 903 - 908 | 
|---|---|
| Main Authors | , , , , , , , , | 
| Format | Journal Article | 
| Language | English Japanese  | 
| Published | 
        Japan
          The Pharmaceutical Society of Japan
    
        01.07.2017
     Pharmaceutical Society of Japan  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0031-6903 1347-5231 1347-5231  | 
| DOI | 10.1248/yakushi.17-00006 | 
Cover
| Abstract | A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community. | 
    
|---|---|
| AbstractList | A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community. A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community. A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a major source of phosphorus, is largely unrecognized in Japan. However, the amount of phosphorus indicated on the package label, is not quantified. In this study, the phosphorus content of 22 of the most widely prescribed medications that are used in conjunction with HD therapy were examined and differences between branded and generic prescription medications were compared. All samples were selected from medications that are typically prescribed for HD patients. The samples were ground prior to analysis. Phosphorus was measured using the Wako L-Type Phosphate method. All instruments used in the study were calibrated according to the manufacturers' specifications. Amlodipine (15 mg/tablet) and paroxetine (30.0 mg/tablet) were found to contain higher contents of phosphorus than the medications tested. Differences in phosphorus content between branded and generic drugs was also determined. The phosphorus content of all generic paroxetine preparations was significantly lower than the values for identical branded medications. On the other hand, the phosphorus content of several generic amlodipine preparations were significantly different from those of similar, branded preparations. Specific information regarding the phosphorus content of prescribed medications used by HD patient needs to be made available to the dialysis community.  | 
    
| Author | Kadowaki, Daisuke Zingami, Sachiko Iohara, Daisuke Hirayama, Fumitoshi Uto, Ayako Maruyama, Toru Shimoishi, Kazuki Otagiri, Masaki Anraku, Makoto  | 
    
| Author_xml | – sequence: 1 fullname: Hirayama, Fumitoshi organization: Faculty of Pharmaceutical Sciences, Sojo University – sequence: 1 fullname: Iohara, Daisuke organization: Faculty of Pharmaceutical Sciences, Sojo University – sequence: 1 fullname: Otagiri, Masaki organization: Faculty of Pharmaceutical Sciences, Sojo University – sequence: 1 fullname: Anraku, Makoto organization: Faculty of Pharmaceutical Sciences, Sojo University – sequence: 1 fullname: Zingami, Sachiko organization: Department of Pharmacy, Japanese Red Cross Kumamoto Hospital – sequence: 1 fullname: Maruyama, Toru organization: Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University – sequence: 1 fullname: Shimoishi, Kazuki organization: Department of Pharmacy, Japanese Red Cross Kumamoto Hospital – sequence: 1 fullname: Uto, Ayako organization: Minori Dispensing Pharmacy – sequence: 1 fullname: Kadowaki, Daisuke organization: Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28674306$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNqNkkFv1DAQhS1URJfSOyeUI5cUT-zYzrFaQRdUxB7gbDlep3FJ7GAnqvbf4yTbReKA8GHG0rxvZvTs1-jCeWcQegv4BgoqPhzVzym29gZ4jtNhL9AGCOV5WRC4QBuMCeSswuQSXcdoa4yLdEoQr9BlIRinBLMNMrfZ1veDCjZ6l_kmG1uT7Vsfh9aHKaaiG40bM-uyfTBRBzuMNim_moPVar7GrPEh25neH6zqjtHGbJ8KCYoz9UUNyr1BLxvVRXN9ylfox6eP37e7_P7b3eft7X2uOdAxh4YxqjhWpKlqrHBREahJqWtKVWlIRRgWlYBKMEGgrFhBFYVScApJS0VJrhCsfSc3qOOT6jo5BNurcJSA5eyaPLkmgcvFtcS8X5kh-F-TiaPsbdSm65QzfooSqjRCACzSdyfpVPfmcO79bGcSsFWgg48xmEZqOy4ujUHZ7l9L4L_A_9j7bkX65Sk67zrrjHz0U3DJY6kjn5kHWeCZAcLxnCqJ05-YgygqXLISUqfd2ukxjurBnEerMFrdmT-jCZd8ic9LnCW6VUEaR34DFdXL0g | 
    
| CitedBy_id | crossref_primary_10_1038_s41387_019_0080_2 crossref_primary_10_1053_j_jrn_2020_02_003 crossref_primary_10_5649_jjphcs_44_55  | 
    
| Cites_doi | 10.1093/ndt/13.8.2037 10.2215/CJN.07640711 10.2215/CJN.09250912 10.1038/sj.ki.5001514 10.1038/ki.2013.147 10.1111/j.0894-0959.2004.17308.x 10.1681/ASN.V12102131 10.2215/CJN.00810110 10.1111/j.1525-139X.2011.00849.x 10.1111/sdi.12042 10.1093/ndt/gft280 10.1111/j.1525-139X.2007.00204.x 10.1053/j.ajkd.2014.01.429 10.1056/NEJMoa0706130 10.1111/sdi.12159 10.1681/ASN.2008020159 10.1053/ajkd.1998.v31.pm9531176 10.1038/ki.2015.67  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2017 The Pharmaceutical Society of Japan | 
    
| Copyright_xml | – notice: 2017 The Pharmaceutical Society of Japan | 
    
| CorporateAuthor | cDepartment of Biopharmaceutics bFaculty of Pharmaceutical Sciences Graduate School of Pharmaceutical Sciences Japanese Red Cross Kumamoto Hospital Sojo University aDepartment of Pharmacy dMinori Dispensing Pharmacy Kumamoto University  | 
    
| CorporateAuthor_xml | – name: aDepartment of Pharmacy – name: bFaculty of Pharmaceutical Sciences – name: Kumamoto University – name: Graduate School of Pharmaceutical Sciences – name: cDepartment of Biopharmaceutics – name: Sojo University – name: Japanese Red Cross Kumamoto Hospital – name: dMinori Dispensing Pharmacy  | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY  | 
    
| DOI | 10.1248/yakushi.17-00006 | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Pharmacy, Therapeutics, & Pharmacology | 
    
| EISSN | 1347-5231 | 
    
| EndPage | 908 | 
    
| ExternalDocumentID | 10.1248/yakushi.17-00006 28674306 10_1248_yakushi_17_00006 cs7yakug_2017_013707_019_0903_09082905651 article_yakushi_137_7_137_17_00006_article_char_en  | 
    
| Genre | Journal Article Comparative Study  | 
    
| GroupedDBID | .55 123 29R 2WC ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK E3Z EBS EJD F5P GX1 HH5 JMI JSF JSH MOJWN OVT P2P RJT RNS RZJ X7M XSB AAYXX CITATION 53G AFFNX CGR CUY CVF ECM EIF KQ8 LPU NPM X7J 7X8 ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c714t-1f664a70a3f9b0a02931b35cb44a5e39360898198683159624a4158741a024853 | 
    
| IEDL.DBID | UNPAY | 
    
| ISSN | 0031-6903 1347-5231  | 
    
| IngestDate | Wed Oct 01 16:01:50 EDT 2025 Fri Jul 11 09:04:15 EDT 2025 Thu Jan 02 22:22:11 EST 2025 Tue Jul 01 03:47:42 EDT 2025 Thu Apr 24 23:05:27 EDT 2025 Thu Jul 10 16:10:25 EDT 2025 Wed Sep 03 06:27:39 EDT 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 7 | 
    
| Keywords | hemodialysis branded prescribed medication generic phosphorus  | 
    
| Language | English Japanese  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c714t-1f664a70a3f9b0a02931b35cb44a5e39360898198683159624a4158741a024853 | 
    
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_pdf | 
    
| PMID | 28674306 | 
    
| PQID | 1915881106 | 
    
| PQPubID | 23479 | 
    
| PageCount | 6 | 
    
| ParticipantIDs | unpaywall_primary_10_1248_yakushi_17_00006 proquest_miscellaneous_1915881106 pubmed_primary_28674306 crossref_citationtrail_10_1248_yakushi_17_00006 crossref_primary_10_1248_yakushi_17_00006 medicalonline_journals_cs7yakug_2017_013707_019_0903_09082905651 jstage_primary_article_yakushi_137_7_137_17_00006_article_char_en  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2017-07-01 | 
    
| PublicationDateYYYYMMDD | 2017-07-01 | 
    
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Japan | 
    
| PublicationPlace_xml | – name: Japan | 
    
| PublicationTitle | YAKUGAKU ZASSHI | 
    
| PublicationTitleAlternate | YAKUGAKU ZASSHI | 
    
| PublicationYear | 2017 | 
    
| Publisher | The Pharmaceutical Society of Japan Pharmaceutical Society of Japan  | 
    
| Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan  | 
    
| References | 8) Fouque D., Horne R., Cozzolino M., Kalantar-Zadeh K., Am. J. Kidney Dis., 64, 143-150 (2014). 14) Di Iorio B., Di Micco L., Torraca S., Sirico M. L., Russo L., Pota A., Mirenghi F., Russo D., Clin. J. Am. Soc. Nephrol., 7, 581-587 (2012). 15) Isakova T., Barchi-Chung A., Enfield G., Smith K., Vargas G., Houston J., Xie H., Wahl P., Schiavenato E., Dosch A., Gutiérrez O. M., Diego J., Lenz O., Contreras G., Mendez A., Weiner R. B., Wolf M., Clin. J. Am. Soc. Nephrol., 8, 1009-1018 (2013). 16) Daugirdas J. T., Finn W. F., Emmett M., Chertow G. M., Semin. Dial., 24, 41-49 (2011). 10) Sherman R. A., Ravella S., Kapoian T., Kidney Int., 87, 1097-1099 (2015). 18) Clark S., Farrington K., Chilcot J., Semin. Dial., 27, 42-49 (2014). 5) Ribeiro S., Ramos A., Brandão A., Rebelo J. R., Guerra A., Resina C., Vila-Lobos A., Carvalho F., Remédio F., Ribeiro F., Nephrol. Dial. Transplant., 13, 2037-2040 (1998). 13) Ikizler T. A., Cano N. J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M. K., Stenvinkel P., TerWee P., Teta D., Wang A. Y. M., Wanner C., Kidney Int., 84, 1096-1107 (2013). 2) Block G. A., Hulbert-Shearon T. E., Levin N. W., Port F. K., Am. J. Kidney Dis., 31, 607-617 (1998). 1) Gutiérrez O. M., Mannstadt M., Isakova T., Rauh-Hain J. A., Tamez H., Shan A., Smith K., Lee H., Thadhani R., Jüppner H., Wolf M., N. Engl. J. Med., 359, 584-592 (2008). 9) Sherman R. A., Semin Dial., 20, 16-18 (2007). 7) Calvo M. S., Uribarri J., Semin. Dial., 26, 54-61 (2013). 3) Ganesh S. K., Stack A. G., Levin N. W., Hulbert-Shearon T., Port F. K., J. Am. Soc. Nephrol., 12, 2131-2138 (2001). 4) Kalantar-Zadeh K., Kuwae N., Regidor D. L., Kovesdy C. P., Kilpatrick R. D., Shinaberger C. S., McAllister C. J., Budoff M. J., Salusky I. B., Kopple J. D., Kidney Int., 70, 771-780 (2006). 6) Goodman W. G., Semin. Dial., 17, 209-216 (2004). 12) Eddington H., Hoefield R., Sinha S., Chrysochou C., Lane B., Foley R. N., Hegarty J., New J., O'Donoghue D. J., Middleton R. J., Kalra P. A., Clin. J. Am. Soc. Nephrol., 5, 2251-2257 (2010). 17) Wang S., Alfieri T., Ramakrishnan K., Braunhofer P., Newsome B. A., Nephrol. Dial. Transplant., 29, 2092-2099 (2014). 11) Moranne O., Froissart M., Rossert J., Gauci C., Boffa J. J., Haymann J. P., M'rad M. B., Jacquot C., Houillier P., Stengel B., Fouqueray B., NephroTest Study Group, J. Am. Soc. Nephrol., 20, 164-171 (2009). 11 12 13 14 15 16 17 18 1 2 3 4 5 6 7 8 9 10  | 
    
| References_xml | – reference: 1) Gutiérrez O. M., Mannstadt M., Isakova T., Rauh-Hain J. A., Tamez H., Shan A., Smith K., Lee H., Thadhani R., Jüppner H., Wolf M., N. Engl. J. Med., 359, 584-592 (2008). – reference: 3) Ganesh S. K., Stack A. G., Levin N. W., Hulbert-Shearon T., Port F. K., J. Am. Soc. Nephrol., 12, 2131-2138 (2001). – reference: 12) Eddington H., Hoefield R., Sinha S., Chrysochou C., Lane B., Foley R. N., Hegarty J., New J., O'Donoghue D. J., Middleton R. J., Kalra P. A., Clin. J. Am. Soc. Nephrol., 5, 2251-2257 (2010). – reference: 9) Sherman R. A., Semin Dial., 20, 16-18 (2007). – reference: 16) Daugirdas J. T., Finn W. F., Emmett M., Chertow G. M., Semin. Dial., 24, 41-49 (2011). – reference: 8) Fouque D., Horne R., Cozzolino M., Kalantar-Zadeh K., Am. J. Kidney Dis., 64, 143-150 (2014). – reference: 13) Ikizler T. A., Cano N. J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M. K., Stenvinkel P., TerWee P., Teta D., Wang A. Y. M., Wanner C., Kidney Int., 84, 1096-1107 (2013). – reference: 7) Calvo M. S., Uribarri J., Semin. Dial., 26, 54-61 (2013). – reference: 11) Moranne O., Froissart M., Rossert J., Gauci C., Boffa J. J., Haymann J. P., M'rad M. B., Jacquot C., Houillier P., Stengel B., Fouqueray B., NephroTest Study Group, J. Am. Soc. Nephrol., 20, 164-171 (2009). – reference: 2) Block G. A., Hulbert-Shearon T. E., Levin N. W., Port F. K., Am. J. Kidney Dis., 31, 607-617 (1998). – reference: 4) Kalantar-Zadeh K., Kuwae N., Regidor D. L., Kovesdy C. P., Kilpatrick R. D., Shinaberger C. S., McAllister C. J., Budoff M. J., Salusky I. B., Kopple J. D., Kidney Int., 70, 771-780 (2006). – reference: 18) Clark S., Farrington K., Chilcot J., Semin. Dial., 27, 42-49 (2014). – reference: 5) Ribeiro S., Ramos A., Brandão A., Rebelo J. R., Guerra A., Resina C., Vila-Lobos A., Carvalho F., Remédio F., Ribeiro F., Nephrol. Dial. Transplant., 13, 2037-2040 (1998). – reference: 14) Di Iorio B., Di Micco L., Torraca S., Sirico M. L., Russo L., Pota A., Mirenghi F., Russo D., Clin. J. Am. Soc. Nephrol., 7, 581-587 (2012). – reference: 6) Goodman W. G., Semin. Dial., 17, 209-216 (2004). – reference: 17) Wang S., Alfieri T., Ramakrishnan K., Braunhofer P., Newsome B. A., Nephrol. Dial. Transplant., 29, 2092-2099 (2014). – reference: 10) Sherman R. A., Ravella S., Kapoian T., Kidney Int., 87, 1097-1099 (2015). – reference: 15) Isakova T., Barchi-Chung A., Enfield G., Smith K., Vargas G., Houston J., Xie H., Wahl P., Schiavenato E., Dosch A., Gutiérrez O. M., Diego J., Lenz O., Contreras G., Mendez A., Weiner R. B., Wolf M., Clin. J. Am. Soc. Nephrol., 8, 1009-1018 (2013). – ident: 5 doi: 10.1093/ndt/13.8.2037 – ident: 14 doi: 10.2215/CJN.07640711 – ident: 15 doi: 10.2215/CJN.09250912 – ident: 4 doi: 10.1038/sj.ki.5001514 – ident: 13 doi: 10.1038/ki.2013.147 – ident: 6 doi: 10.1111/j.0894-0959.2004.17308.x – ident: 3 doi: 10.1681/ASN.V12102131 – ident: 12 doi: 10.2215/CJN.00810110 – ident: 16 doi: 10.1111/j.1525-139X.2011.00849.x – ident: 7 doi: 10.1111/sdi.12042 – ident: 17 doi: 10.1093/ndt/gft280 – ident: 9 doi: 10.1111/j.1525-139X.2007.00204.x – ident: 8 doi: 10.1053/j.ajkd.2014.01.429 – ident: 1 doi: 10.1056/NEJMoa0706130 – ident: 18 doi: 10.1111/sdi.12159 – ident: 11 doi: 10.1681/ASN.2008020159 – ident: 2 doi: 10.1053/ajkd.1998.v31.pm9531176 – ident: 10 doi: 10.1038/ki.2015.67  | 
    
| SSID | ssib002222518 ssib002484306 ssib001136365 ssib002223935 ssib002484304 ssib002484305 ssib000959844 ssib002822080 ssib003105265 ssib023161479 ssj0023355 ssib000576198 ssib002499502 ssib003105266 ssib000937675 ssib000972830 ssib001536036 ssib002222551 ssib058494605 ssib058494604  | 
    
| Score | 2.1051626 | 
    
| Snippet | A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a... | 
    
| SourceID | unpaywall proquest pubmed crossref medicalonline jstage  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 903 | 
    
| SubjectTerms | Amlodipine - chemistry branded Drugs, Generic - chemistry generic hemodialysis Humans Japan Paroxetine - chemistry phosphorus Phosphorus - adverse effects Phosphorus - analysis Phosphorus, Dietary - adverse effects Phosphorus, Dietary - analysis prescribed medication Prescription Drugs - chemistry Renal Dialysis  | 
    
| Title | A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan | 
    
| URI | https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_article/-char/en http://mol.medicalonline.jp/library/journal/download?GoodsID=cs7yakug/2017/013707/019&name=0903-0908e https://www.ncbi.nlm.nih.gov/pubmed/28674306 https://www.proquest.com/docview/1915881106 https://www.jstage.jst.go.jp/article/yakushi/137/7/137_17-00006/_pdf  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 137 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| ispartofPNX | YAKUGAKU ZASSHI, 2017/07/01, Vol.137(7), pp.903-908 | 
    
| journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1347-5231 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023355 issn: 0031-6903 databaseCode: HH5 dateStart: 18810101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1347-5231 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023355 issn: 0031-6903 databaseCode: DIK dateStart: 19470101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1347-5231 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0023355 issn: 0031-6903 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NDgkmxPdG-ZiMhCYxLW1SO19vVIOpDDH1YZXGk-UkTsfWJdWSCJW_nrs4SRlCIMRL8pC7kz_O559j388AbwKbptE0sGw34ZbgSWIpRygrVZT16KY-9yjB-fOJN5mJ4zP3bAPet7kwdKzyAnHRXNNrMM8HF8th04jDlbqsinMc6dwf-vSUGGLriDuUyyS9BZuei4i8B5uzk-n4i2FkdCxcANbn7Lnwad3lNLuVIxG0FgetnRuz021TkC24d2U2TQx5xe-w6BbcqbKlWn1Ti8VP89PRA9BtzcyxlMtBVUaD-PsvpI__W_WHcL8BsGxsNB7Bhs4ew97UMGCvDtjpOqGrOGB7bLrmxl49AT1mh93NhyxPGeJPFMmL5Xl-XRWsJsvKSvY1Y3Q4pA1pzOwn1WOEIcxmE32VU8oL8amwqeGGLUjrGCf_7CnMjj6cHk6s5qYHK_YdUVpO6nlC-bbiaRjZykYM4kTcjSMhlKt5yD07CBG7BF7AHbovSCgEHgGiIVVzsvFt6GV5pp8BSxOtoyTUIiJvQ_A4QgdEEJhqwVMU7cOw7WEZNzTodBvHQtJyCI3JpqmxgWXdwH1422ksDQXIH2THpgs7yaYD15LYdb40HWh0OhHKs8Ng1Yd3N_xNNlGlkHHhk5m5RNSGymjEplco6WcbPWhXHBG604fXrYtKDBe0B6QynVeFxOW5GwSI-bCoO8Z3u6KOAspIoS_7nTP_tcbP_0X4Bdylopvjzi-hV15X-hWCujLaxeXMx0-7zcj9AQ9pShQ | 
    
| linkProvider | Unpaywall | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED-6dLCWse9u2RcajMJG7diR_JG3hW4lFFby0ED3JGRbStemdqhjRvbX786ynXWMjbEX-8F3QtKdTj9Zup8A3sYeTaMmdrwg447gWeYoXyjHKMp6DEzEQ0pw_nwSTmbi-Cw424KPbS4MHau8QFw01_Ry54V7sRw0nThYq8uqPMeRzqNBRE-JIbaOuAO5zMwt2A4DROQ92J6dTMdfLCOj7-ACsD5nz0VE6y6_2a0cirgt0W3LuTE73bYV2YW7V3bTxJJX_A6L7sKdKl-q9Te1WPw0Px3dB922zB5LuXSrVeKm338hffzfpj-Aew2AZWOr8RC2dP4I9qeWAXt9wE43CV3lAdtn0w039vox6DE77G4-ZIVhiD9RpCiX58V1VbKaLCtfsa85o8MhbUhjdj-pHiMMYTab6KuCUl6IT4VNLTdsSVrHOPnnT2B29On0cOI0Nz04aeSLleObMBQq8hQ3o8RTHmIQP-FBmgihAs1HPPTiEWKXOIy5T_cFCYXAI0Y0pGpONr4HvbzI9TNgJtM6yUZaJORtCB6H6IAIAo0W3KBoHwathWXa0KDTbRwLScshLEw2XY0dLOsO7sO7TmNpKUD-IDu2JuwkGwNuJNF0kbQGtDqdCOXZYbDqw4cb_iabqFLKtIyomLlE1IbKWIhHr5Gkn230oF1xROh-H960LioxXNAekMp1UZUSl-dBHCPmw6o-tb7bVXUYU0YKfXnfOfNfW_z8X4RfwA5V3R53fgm91XWlXyGoWyWvmzH7A1iYSRs | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Comparison+of+the+Phosphorus+Content+in+Prescription+Medications+for+Hemodialysis+Patients+in+Japan&rft.jtitle=Yakugaku+zasshi&rft.au=Shimoishi%2C+Kazuki&rft.au=Anraku%2C+Makoto&rft.au=Uto%2C+Ayako&rft.au=Iohara%2C+Daisuke&rft.date=2017-07-01&rft.eissn=1347-5231&rft.volume=137&rft.issue=7&rft.spage=903&rft_id=info:doi/10.1248%2Fyakushi.17-00006&rft_id=info%3Apmid%2F28674306&rft.externalDocID=28674306 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6903&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6903&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6903&client=summon |